Weaver C. Barksdale & Associates’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4K Buy
64
+6
+10% +$382 ﹤0.01% 390
2017
Q3
$3K Sell
58
-8
-12% -$406 ﹤0.01% 414
2017
Q2
$3K Sell
66
-12
-15% -$533 ﹤0.01% 427
2017
Q1
$3K Hold
78
﹤0.01% 436
2016
Q4
$2K Sell
78
-6
-7% -$172 ﹤0.01% 474
2016
Q3
$2K Sell
84
-28
-25% -$672 ﹤0.01% 468
2016
Q2
$2K Hold
112
﹤0.01% 455
2016
Q1
$2K Hold
112
﹤0.01% 477
2015
Q4
$2K Sell
112
-10
-8% -$178 ﹤0.01% 473
2015
Q3
$2K Buy
122
+26
+27% +$517 ﹤0.01% 474
2015
Q2
$2K Hold
96
﹤0.01% 484
2015
Q1
$2K Hold
96
﹤0.01% 495
2014
Q4
$2K Buy
96
+16
+20% +$319 ﹤0.01% 489
2014
Q3
$2K Buy
+80
New +$1.65K ﹤0.01% 482

Other funds holding CGNX

Weaver C. Barksdale & Associates's CGNX Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Cognex (CGNX) stake by 10% in Q4 2017, buying an estimated $382 and bringing the position to 64 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Weaver C. Barksdale & Associates first reported a position in CGNX in Q3 2014 and has held it in 14 quarters since. 494 funds tracked by Wall St. Rank hold CGNX as of Q4 2017.

  • Weaver C. Barksdale & Associates held 64 shares of Cognex worth $4K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 6 Cognex shares in Q4 2017, an estimated $382.
  • Cognex made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #390 holding.
  • Weaver C. Barksdale & Associates first reported a position in Cognex in Q3 2014 and has held it in 14 quarters since.
  • 494 funds tracked by Wall St. Rank held Cognex as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.